Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 439

Showing 51-75 of 439 citing articles:

Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review)
Ye Ding, Yong Yu
Molecular Medicine Reports (2025) Vol. 31, Iss. 4, pp. 1-34
Closed Access | Times Cited: 1
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer
Xingyu Chen, Lixiang Feng, Yujing Huang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 37
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 21
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12963-12963
Open Access | Times Cited: 20
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery
Charlotte Stutzmann, Jiaxi Peng, Zhaoguan Wu, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 6, pp. 100511-100511
Open Access | Times Cited: 18
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 18
Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Cellular Immunology (2023) Vol. 5, Iss. 4, pp. 127-140
Open Access | Times Cited: 18
Tumor neoantigens: Novel strategies for application of cancer immunotherapy
Hanyang Guan, Yue Wu, Lu Li, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 437-448
Open Access | Times Cited: 17
H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy
Chu Xiao, Tao Fan, Yujia Zheng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e005693-e005693
Open Access | Times Cited: 16
The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
Chiranjib Chakraborty, Anirban Majumder, Manojit Bhattacharya, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100177-100177
Open Access | Times Cited: 7
Optimising IL-2 for Cancer Immunotherapy
Jonathan Sprent, Onur Boyman
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors
Xiaoying Liu, Fangmin Chen, Madiha Saeed, et al.
Nano Today (2024) Vol. 56, pp. 102273-102273
Closed Access | Times Cited: 7
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma
Sofie Kirial Mørk, Signe K. Skadborg, Benedetta Albieri, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008817-e008817
Open Access | Times Cited: 7
Impact of HLA class I functional divergence on HIV control
Mathias Viard, Colm Ó’hUigín, Yuko Yuki, et al.
Science (2024) Vol. 383, Iss. 6680, pp. 319-325
Open Access | Times Cited: 6
Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine
Suyang Wang, Chao‐Cheng Chen, Ming‐Hung Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy
Komal Kumari, Amarnath Singh, Archana Chaudhary, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 498-498
Open Access | Times Cited: 6
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
Xiao-kun Zhang, Ye Wu, Jia-Yi Lin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3818-3833
Open Access | Times Cited: 6
Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies
Haolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117252-117252
Open Access | Times Cited: 6
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
Christine Moussion, Lélia Delamarre
Seminars in Immunology (2023) Vol. 71, pp. 101848-101848
Closed Access | Times Cited: 15
Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer
Gayathri Kandasamy, Yugeshwaran Karuppasamy, Uma Maheswari Krishnan
Vaccines (2023) Vol. 11, Iss. 2, pp. 458-458
Open Access | Times Cited: 14
Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools
Maria Karolaynne da Silva, Daniel Melo de Oliveira Campos, Shopnil Akash, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2130-2130
Open Access | Times Cited: 14

Scroll to top